Our Mission
With over 50 years of combined experience advising and investing into the UK health and social care sector, NEK is on a mission to provide exceptional care to adults across the specialist care markets.
Understanding, improving and growing these businesses is what drives us, with the objective of meeting the needs and making a difference to our clients' lives.
Market dynamics continue to create outstanding opportunities to unlock long-term value and deliver meaningful social impact.
Why Invest with NEK?
01
Proven
expertise
A leadership team with deep experience across healthcare, private equity, finance, and real estate.
02
Strong market fundamentals
Long-term demographic trends, attractive supply/demand dynamics, and reliable counterparties.
03
Resilient
cashflows
The sector is underpinned by government-backed funding, ensuring stability and growth potential.
04
Socially Responsible Investing
Join us on our journey to change lives, delivering exceptional care in high quality buildings.
Paul Nelson
Paul qualified as a Chartered Accountant (ACA) before moving into senior management in professional services. He then joined Nuffield Health, overseeing group cashflow, before moving to Syngenta in international reporting, revenue structuring, and M&A. Most recently, Paul was Partner and CFO at a boutique private equity firm. He holds a degree in Economics and is a Fellow of the ICAEW (FCA).
Paddy Evans
Paddy spent nearly 20 years at Knight Frank, where he led the healthcare corporate advisory and valuation team, working on major social care transactions and IPOs for operators, developers, and investment funds. In 2022, he joined a boutique private equity firm as Investment Director, leading acquisitions and development in the specialist care sector.
John Knight
John began his career at the European Parliament before moving into finance with Murano Connect and Apex Capital Introduction Services. He later became Head of Investor Relations & Partner at a boutique private equity firm, where he spent seven years leading fundraising and investor relations. John brings extensive expertise in alternative investments, spanning both research and capital raising.